Ker Y. Cheah

490 total citations
13 papers, 408 citations indexed

About

Ker Y. Cheah is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Ker Y. Cheah has authored 13 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 5 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Ker Y. Cheah's work include Oral health in cancer treatment (9 papers), Neutropenia and Cancer Infections (4 papers) and Cancer therapeutics and mechanisms (3 papers). Ker Y. Cheah is often cited by papers focused on Oral health in cancer treatment (9 papers), Neutropenia and Cancer Infections (4 papers) and Cancer therapeutics and mechanisms (3 papers). Ker Y. Cheah collaborates with scholars based in Australia, United States and United Kingdom. Ker Y. Cheah's co-authors include Gordon S. Howarth, Susan E.P. Bastian, Kerry A. Lymn, Roger Yazbeck, Ross N. Butler, James A. Kennedy, Keren A. Bindon, Suzanne Mashtoub, Andrew J. Lawrence and Adrian G. Cummins and has published in prestigious journals such as Gastroenterology, PLoS ONE and World Journal of Gastroenterology.

In The Last Decade

Ker Y. Cheah

13 papers receiving 395 citations

Peers

Ker Y. Cheah
Ker Y. Cheah
Citations per year, relative to Ker Y. Cheah Ker Y. Cheah (= 1×) peers Luca D. Prisciandaro

Countries citing papers authored by Ker Y. Cheah

Since Specialization
Citations

This map shows the geographic impact of Ker Y. Cheah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ker Y. Cheah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ker Y. Cheah more than expected).

Fields of papers citing papers by Ker Y. Cheah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ker Y. Cheah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ker Y. Cheah. The network helps show where Ker Y. Cheah may publish in the future.

Co-authorship network of co-authors of Ker Y. Cheah

This figure shows the co-authorship network connecting the top 25 collaborators of Ker Y. Cheah. A scholar is included among the top collaborators of Ker Y. Cheah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ker Y. Cheah. Ker Y. Cheah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Mashtoub, Suzanne, et al.. (2018). Comparative effects of mistletoe extracts in combination with 5-Fluorouracil on viability of IEC-6 and Caco-2 intestinal epithelial cells. 30(4). 174. 1 indexed citations
2.
Mashtoub, Suzanne, Ker Y. Cheah, Kerry A. Lymn, & Gordon S. Howarth. (2018). Intestinal homeostasis is restored in mice following a period of intestinal growth induced by orally administered Emu Oil. Experimental Biology and Medicine. 243(11). 945–952. 7 indexed citations
3.
Mashtoub, Suzanne, et al.. (2016). Emu Oil Combined with Lyprinol™ Reduces Small Intestinal Damage in a Rat Model of Chemotherapy-Induced Mucositis. Nutrition and Cancer. 68(7). 1171–1180. 19 indexed citations
4.
Eden, Georgina L., Ker Y. Cheah, Kerry A. Lymn, et al.. (2016). Rhubarb extract partially improves mucosal integrity in chemotherapy-induced intestinal mucositis. World Journal of Gastroenterology. 22(37). 8322–8322. 21 indexed citations
5.
Cheah, Ker Y., Gordon S. Howarth, Keren A. Bindon, James A. Kennedy, & Susan E.P. Bastian. (2014). Low Molecular Weight Procyanidins from Grape Seeds Enhance the Impact of 5-Fluorouracil Chemotherapy on Caco-2 Human Colon Cancer Cells. PLoS ONE. 9(6). e98921–e98921. 51 indexed citations
6.
Wang, Hanru, Susan E.P. Bastian, Ker Y. Cheah, Andrew J. Lawrence, & Gordon S. Howarth. (2014). Escherichia coliNissle 1917-derived factors reduce cell death and late apoptosis and increase transepithelial electrical resistance in a model of 5-fluorouracil-induced intestinal epithelial cell damage. Cancer Biology & Therapy. 15(5). 560–569. 17 indexed citations
7.
Cheah, Ker Y., Gordon S. Howarth, & Susan E.P. Bastian. (2014). Grape Seed Extract Dose-Responsively Decreases Disease Severity in a Rat Model of Mucositis; Concomitantly Enhancing Chemotherapeutic Effectiveness in Colon Cancer Cells. PLoS ONE. 9(1). e85184–e85184. 52 indexed citations
8.
Cheah, Ker Y., Gordon S. Howarth, Keren A. Bindon, et al.. (2014). Sa1963 Low Molecular Weight Procyanidins From Grape Seeds Enhance the Impact of 5-Fluorouracil Chemotherapy on Colon Cancer Cells. Gastroenterology. 146(5). S–341. 2 indexed citations
9.
Cheah, Ker Y., et al.. (2012). Grape Seed Extract Reduces the Severity of Selected Disease Markers in the Proximal Colon of Dextran Sulphate Sodium-Induced Colitis in Rats. Digestive Diseases and Sciences. 58(4). 970–977. 60 indexed citations
10.
Cheah, Ker Y., et al.. (2009). Grape seed extract: effects on chemotherapy-induced mucositis and inflammatory bowel disease in rats. Supportive Care in Cancer. 1 indexed citations
12.
Yazbeck, Roger, Kerry A. Lymn, Ker Y. Cheah, et al.. (2009). The herbal extract Iberogast® improves jejunal integrity in rats with 5-Fluorouracil (5-FU)-induced mucositis. Cancer Biology & Therapy. 8(10). 923–929. 52 indexed citations
13.
Cummins, Adrian G., Ross N. Butler, Luca D. Prisciandaro, et al.. (2009). Effects of Streptococcus thermophilus TH-4 on intestinal mucositis induced by the chemotherapeutic agent, 5-Fluorouracil (5-FU). Cancer Biology & Therapy. 8(6). 505–511. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026